444588-39-0 Usage
Uses
Used in Medicinal Chemistry and Pharmaceutical Research:
6-NITROISOCHROMAN is used as a building block for the development of new drugs and drug candidates, contributing to the advancement of medicinal chemistry and pharmaceutical research.
Used in Organic Synthesis:
6-NITROISOCHROMAN is used as a building block for the production of more complex molecules, playing a crucial role in the field of organic synthesis.
Used as a Reagent in Chemical Reactions:
6-NITROISOCHROMAN is utilized as a reagent in various chemical reactions, facilitating the synthesis of different chemical compounds.
Used as a Precursor for Chemical Compound Preparation:
6-NITROISOCHROMAN serves as a precursor for the preparation of different chemical compounds, enabling the creation of a wide range of products in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 444588-39-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,4,5,8 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 444588-39:
(8*4)+(7*4)+(6*4)+(5*5)+(4*8)+(3*8)+(2*3)+(1*9)=180
180 % 10 = 0
So 444588-39-0 is a valid CAS Registry Number.
444588-39-0Relevant articles and documents
INHIBITORS OF CHECKPOINT KINASES
-
, (2008/06/13)
The instant invention provides for compounds which comprise fused pyrazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound
PIPERAZINYLPHENALKYL LACTAM/AMINE LIGANDS FOR THE 5HT1B RECEPTOR
-
Page/Page column 70, (2010/11/30)
The present invention relates to novel derivatives, that are compounds of Formula (I), wherein R1, R2, R3, R14, X, Y, n and m are defined herein, their pharmaceutically acceptable salts, pharmaceutical compositions and methods using said compounds in treating or preventing depression, anxiety, obsessive compulsive disorder (OCD) and other disorders for which selective antagonists, inverse agonists and partial agonists of serotonin 1 (5-HT1) receptors, specifically, antagonists of 5-HT1B are useful.